127 related articles for article (PubMed ID: 9609244)
1. Ancylostoma caninum anticoagulant peptide blocks metastasis in vivo and inhibits factor Xa binding to melanoma cells in vitro.
Donnelly KM; Bromberg ME; Milstone A; Madison McNiff JM; Terwilliger G; Konigsberg WH; Cappello M
Thromb Haemost; 1998 May; 79(5):1041-7. PubMed ID: 9609244
[TBL] [Abstract][Full Text] [Related]
2. Ancylostoma ceylanicum anticoagulant peptide-1: role of the predicted reactive site amino acid in mediating inhibition of coagulation factors Xa and VIIa.
Mieszczanek J; Harrison LM; Cappello M
Mol Biochem Parasitol; 2004 Sep; 137(1):151-9. PubMed ID: 15279961
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of the prothrombinase complex: factor Va alters macromolecular recognition of a tick anticoagulant peptide mutant by factor Xa.
Betz A; Vlasuk GP; Bergum PW; Krishnaswamy S
Biochemistry; 1997 Jan; 36(1):181-91. PubMed ID: 8993332
[TBL] [Abstract][Full Text] [Related]
4. Intermolecular interactions and characterization of the novel factor Xa exosite involved in macromolecular recognition and inhibition: crystal structure of human Gla-domainless factor Xa complexed with the anticoagulant protein NAPc2 from the hematophagous nematode Ancylostoma caninum.
Murakami MT; Rios-Steiner J; Weaver SE; Tulinsky A; Geiger JH; Arni RK
J Mol Biol; 2007 Feb; 366(2):602-10. PubMed ID: 17173931
[TBL] [Abstract][Full Text] [Related]
5. Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo.
Herbert J; Bono F; Herault J; Avril C; Dol F; Mares A; Schaeffer P
J Clin Invest; 1998 Mar; 101(5):993-1000. PubMed ID: 9486969
[TBL] [Abstract][Full Text] [Related]
6. An anticoagulant peptide from the human hookworm, Ancylostoma duodenale that inhibits coagulation factors Xa and XIa.
Gan W; Deng L; Yang C; He Q; Hu J; Yin H; Jin X; Lu C; Wu Y; Peng L
FEBS Lett; 2009 Jun; 583(12):1976-80. PubMed ID: 19446556
[TBL] [Abstract][Full Text] [Related]
7. Active and exo-site inhibition of human factor Xa: structure of des-Gla factor Xa inhibited by NAP5, a potent nematode anticoagulant protein from Ancylostoma caninum.
Rios-Steiner JL; Murakami MT; Tulinsky A; Arni RK
J Mol Biol; 2007 Aug; 371(3):774-86. PubMed ID: 17588602
[TBL] [Abstract][Full Text] [Related]
8. Effective inhibition of experimental metastasis and prolongation of survival in mice by a potent factor Xa-specific synthetic serine protease inhibitor with weak anticoagulant activity.
Banke IJ; Arlt MJ; Mueller MM; Sperl S; Stemberger A; Stürzebecher J; Amirkhosravi A; Moroder L; Krüger A
Thromb Haemost; 2005 Nov; 94(5):1084-93. PubMed ID: 16363253
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a novel, potent, and specific family of factor Xa inhibitors via combinatorial chemistry.
Ostrem JA; al-Obeidi F; Safar P; Safarova A; Stringer SK; Patek M; Cross MT; Spoonamore J; LoCascio JC; Kasireddy P; Thorpe DS; Sepetov N; Lebl M; Wildgoose P; Strop P
Biochemistry; 1998 Jan; 37(4):1053-9. PubMed ID: 9454596
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism.
Hembrough TA; Swartz GM; Papathanassiu A; Vlasuk GP; Rote WE; Green SJ; Pribluda VS
Cancer Res; 2003 Jun; 63(11):2997-3000. PubMed ID: 12782609
[TBL] [Abstract][Full Text] [Related]
11. Recombinant tissue factor pathway inhibitor enhances the binding of factor Xa to human monocytes.
Li A; Chang AC; Peer GT; Wun TC; Taylor FB
Thromb Haemost; 2001 May; 85(5):830-6. PubMed ID: 11372676
[TBL] [Abstract][Full Text] [Related]
12. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
Camire RM; Kalafatis M; Tracy PB
Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
[TBL] [Abstract][Full Text] [Related]
13. Assembly and regulation of prothrombinase complex on B16F10 melanoma cells.
Kirszberg C; Rumjanek VM; Monteiro RQ
Thromb Res; 2005; 115(1-2):123-9. PubMed ID: 15567463
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of factor Xa inhibition by recombinant tick anticoagulant peptide: both active site and exosite interactions are required for a slow- and tight-binding inhibition mechanism.
Rezaie AR
Biochemistry; 2004 Mar; 43(12):3368-75. PubMed ID: 15035608
[TBL] [Abstract][Full Text] [Related]
15. Human umbilical vein endothelial cells express high affinity receptors for factor Xa.
Bono F; Herault JP; Avril C; Schaeffer P; Lormeau JC; Herbert JM
J Cell Physiol; 1997 Jul; 172(1):36-43. PubMed ID: 9207923
[TBL] [Abstract][Full Text] [Related]
16. Ancylostoma caninum anticoagulant peptide: cloning by PCR and expression of soluble, active protein in E. coli.
Cappello M; Hawdon JM; Jones BF; Kennedy WP; Hotez PJ
Mol Biochem Parasitol; 1996 Sep; 80(1):113-7. PubMed ID: 8885227
[TBL] [Abstract][Full Text] [Related]
17. Regulation of prothrombinase activity by protein S.
van 't Veer C; Butenas S; Golden NJ; Mann KG
Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
[TBL] [Abstract][Full Text] [Related]
18. A new factor Xa inhibitor (lefaxin) from the Haementeria depressa leech.
Faria F; Kelen EM; Sampaio CA; Bon C; Duval N; Chudzinski-Tavassi AM
Thromb Haemost; 1999 Nov; 82(5):1469-73. PubMed ID: 10595640
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of B16-BL6 melanoma lung colonies by semisynthetic sulfaminoheparosan sulfates from E. coli K5 polysaccharide.
Poggi A; Rossi C; Casella N; Bruno C; Sturiale L; Dossi C; Naggi A
Semin Thromb Hemost; 2002 Aug; 28(4):383-92. PubMed ID: 12244486
[TBL] [Abstract][Full Text] [Related]
20. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
Monteiro RQ; Zingali RB
Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
